Faron Pharmaceuticals Oy
Get $10 bonus on your first $100 deposit for FPHAF
Get $10 bonus on your first $100 deposit for FPHAF
Faron Pharmaceuticals Oy (FPHAF) Stock Competitors & Peer Comparison
See (FPHAF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FPHAF | $3.30 | +0.00% | 209.5M | -7.50 | -$0.44 | N/A |
| NONOF | $37.12 | +5.97% | 159.3B | 10.07 | $3.56 | +3.97% |
| CSLLY | $24.98 | -0.60% | 96.9B | 16.25 | $1.54 | +2.92% |
| UCBJY | $159.36 | +2.13% | 60.7B | 34.27 | $4.65 | +0.50% |
| UCBJF | $318.65 | -2.37% | 60.7B | 34.34 | $9.28 | +0.50% |
| CMXHF | $98.24 | +11.26% | 47.7B | 15.92 | $6.17 | +2.96% |
| ARGNF | $712.03 | +0.00% | 44.1B | 36.36 | $19.58 | N/A |
| IVBXF | $11.15 | -2.19% | 19.2B | 159.21 | $0.07 | N/A |
| WXIBF | $4.60 | +0.00% | 19B | 27.06 | $0.17 | N/A |
| WXXWY | $9.10 | +2.36% | 18.7B | 26.59 | $0.34 | N/A |
Stock Comparison
FPHAF vs NONOF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NONOF has a market cap of 159.3B. Regarding current trading prices, FPHAF is priced at $3.30, while NONOF trades at $37.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NONOF's P/E ratio is 10.07. In terms of profitability, FPHAF's ROE is +0.00%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, FPHAF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NONOF's competition here
FPHAF vs CSLLY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSLLY has a market cap of 96.9B. Regarding current trading prices, FPHAF is priced at $3.30, while CSLLY trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSLLY's P/E ratio is 16.25. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, FPHAF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CSLLY's competition here
FPHAF vs UCBJY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJY has a market cap of 60.7B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJY trades at $159.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJY's P/E ratio is 34.27. In terms of profitability, FPHAF's ROE is +0.00%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, FPHAF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJY's competition here
FPHAF vs UCBJF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, UCBJF has a market cap of 60.7B. Regarding current trading prices, FPHAF is priced at $3.30, while UCBJF trades at $318.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas UCBJF's P/E ratio is 34.34. In terms of profitability, FPHAF's ROE is +0.00%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, FPHAF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check UCBJF's competition here
FPHAF vs CMXHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMXHF has a market cap of 47.7B. Regarding current trading prices, FPHAF is priced at $3.30, while CMXHF trades at $98.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMXHF's P/E ratio is 15.92. In terms of profitability, FPHAF's ROE is +0.00%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, FPHAF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CMXHF's competition here
FPHAF vs ARGNF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ARGNF has a market cap of 44.1B. Regarding current trading prices, FPHAF is priced at $3.30, while ARGNF trades at $712.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ARGNF's P/E ratio is 36.36. In terms of profitability, FPHAF's ROE is +0.00%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, FPHAF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
FPHAF vs IVBXF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVBXF has a market cap of 19.2B. Regarding current trading prices, FPHAF is priced at $3.30, while IVBXF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVBXF's P/E ratio is 159.21. In terms of profitability, FPHAF's ROE is +0.00%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, FPHAF and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
FPHAF vs WXIBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXIBF has a market cap of 19B. Regarding current trading prices, FPHAF is priced at $3.30, while WXIBF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXIBF's P/E ratio is 27.06. In terms of profitability, FPHAF's ROE is +0.00%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, FPHAF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
FPHAF vs WXXWY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, WXXWY has a market cap of 18.7B. Regarding current trading prices, FPHAF is priced at $3.30, while WXXWY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas WXXWY's P/E ratio is 26.59. In terms of profitability, FPHAF's ROE is +0.00%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, FPHAF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check WXXWY's competition here
FPHAF vs GNMSF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNMSF has a market cap of 18.4B. Regarding current trading prices, FPHAF is priced at $3.30, while GNMSF trades at $298.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNMSF's P/E ratio is 19.43. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, FPHAF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GNMSF's competition here
FPHAF vs SBHMY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBHMY has a market cap of 14.2B. Regarding current trading prices, FPHAF is priced at $3.30, while SBHMY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBHMY's P/E ratio is 41.82. In terms of profitability, FPHAF's ROE is +0.00%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, FPHAF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
FPHAF vs SBMFF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, FPHAF is priced at $3.30, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SBMFF's P/E ratio is 25.30. In terms of profitability, FPHAF's ROE is +0.00%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, FPHAF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
FPHAF vs BRRGF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, FPHAF is priced at $3.30, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, FPHAF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BRRGF's competition here
FPHAF vs AAVXF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, FPHAF is priced at $3.30, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, FPHAF's ROE is +0.00%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, FPHAF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
FPHAF vs ODTC Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, FPHAF is priced at $3.30, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ODTC's P/E ratio is 1.07. In terms of profitability, FPHAF's ROE is +0.00%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, FPHAF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
FPHAF vs TRSBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, FPHAF is priced at $3.30, while TRSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRSBF's P/E ratio is 21.43. In terms of profitability, FPHAF's ROE is +0.00%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, FPHAF and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
FPHAF vs AKBLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, FPHAF is priced at $3.30, while AKBLF trades at $31.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AKBLF's P/E ratio is 37.77. In terms of profitability, FPHAF's ROE is +0.00%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, FPHAF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
FPHAF vs REGMF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, FPHAF is priced at $3.30, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas REGMF's P/E ratio is 57.63. In terms of profitability, FPHAF's ROE is +0.00%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, FPHAF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
FPHAF vs ABCZF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, FPHAF is priced at $3.30, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, FPHAF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
FPHAF vs LABFF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, FPHAF is priced at $3.30, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas LABFF's P/E ratio is 28.95. In terms of profitability, FPHAF's ROE is +0.00%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, FPHAF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
FPHAF vs SHJBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, FPHAF is priced at $3.30, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, FPHAF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
FPHAF vs ZLDPF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ZLDPF has a market cap of 3.3B. Regarding current trading prices, FPHAF is priced at $3.30, while ZLDPF trades at $46.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ZLDPF's P/E ratio is 3.74. In terms of profitability, FPHAF's ROE is +0.00%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, FPHAF and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
FPHAF vs CAMRF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, FPHAF is priced at $3.30, while CAMRF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CAMRF's P/E ratio is 42.64. In terms of profitability, FPHAF's ROE is +0.00%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, FPHAF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
FPHAF vs TLPPF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TLPPF has a market cap of 3.3B. Regarding current trading prices, FPHAF is priced at $3.30, while TLPPF trades at $9.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TLPPF's P/E ratio is -485.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, FPHAF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TLPPF's competition here
FPHAF vs ASPHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, FPHAF is priced at $3.30, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, FPHAF and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
FPHAF vs GNNSF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, FPHAF is priced at $3.30, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, FPHAF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
FPHAF vs BRCTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, FPHAF is priced at $3.30, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRCTF's P/E ratio is 27.07. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, FPHAF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
FPHAF vs MPSYF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, FPHAF is priced at $3.30, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, FPHAF's ROE is +0.00%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, FPHAF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MPSYF's competition here
FPHAF vs BVNKF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNKF trades at $31.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNKF's P/E ratio is 11.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, FPHAF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BVNKF's competition here
FPHAF vs BVNRY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BVNRY has a market cap of 2.4B. Regarding current trading prices, FPHAF is priced at $3.30, while BVNRY trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BVNRY's P/E ratio is 11.15. In terms of profitability, FPHAF's ROE is +0.00%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, FPHAF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BVNRY's competition here
FPHAF vs INCPF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, FPHAF is priced at $3.30, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INCPF's P/E ratio is 25.83. In terms of profitability, FPHAF's ROE is +0.00%, compared to INCPF's ROE of +0.09%. Regarding short-term risk, FPHAF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
FPHAF vs ASCLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ASCLF has a market cap of 2.2B. Regarding current trading prices, FPHAF is priced at $3.30, while ASCLF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ASCLF's P/E ratio is -35.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, FPHAF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
FPHAF vs GENSF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, FPHAF is priced at $3.30, while GENSF trades at $33.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GENSF's P/E ratio is 35.27. In terms of profitability, FPHAF's ROE is +0.00%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, FPHAF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
FPHAF vs GLPGF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GLPGF has a market cap of 2.2B. Regarding current trading prices, FPHAF is priced at $3.30, while GLPGF trades at $33.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GLPGF's P/E ratio is -4.15. In terms of profitability, FPHAF's ROE is +0.00%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, FPHAF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
FPHAF vs MEOBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MEOBF has a market cap of 2.1B. Regarding current trading prices, FPHAF is priced at $3.30, while MEOBF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MEOBF's P/E ratio is -22.86. In terms of profitability, FPHAF's ROE is +0.00%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, FPHAF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
FPHAF vs PHMMF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, FPHAF is priced at $3.30, while PHMMF trades at $100.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHMMF's P/E ratio is 43.74. In terms of profitability, FPHAF's ROE is +0.00%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, FPHAF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
FPHAF vs BIESF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, FPHAF is priced at $3.30, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BIESF's P/E ratio is -44.44. In terms of profitability, FPHAF's ROE is +0.00%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, FPHAF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
FPHAF vs CSPHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSPHF has a market cap of 1.5B. Regarding current trading prices, FPHAF is priced at $3.30, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, FPHAF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CSPHF's competition here
FPHAF vs ONTTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ONTTF has a market cap of 1.4B. Regarding current trading prices, FPHAF is priced at $3.30, while ONTTF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ONTTF's P/E ratio is -7.15. In terms of profitability, FPHAF's ROE is +0.00%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, FPHAF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check ONTTF's competition here
FPHAF vs HBMHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, FPHAF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
FPHAF vs SNBIF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, FPHAF is priced at $3.30, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, FPHAF's ROE is +0.00%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, FPHAF and SNBIF have similar daily volatility (0.00).Check SNBIF's competition here
FPHAF vs MDCLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, FPHAF is priced at $3.30, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, FPHAF's ROE is +0.00%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, FPHAF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
FPHAF vs IDRSF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while IDRSF trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IDRSF's P/E ratio is -6.74. In terms of profitability, FPHAF's ROE is +0.00%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, FPHAF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
FPHAF vs CSBTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while CSBTF trades at $27.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CSBTF's P/E ratio is 347.38. In terms of profitability, FPHAF's ROE is +0.00%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, FPHAF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
FPHAF vs PPTDF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PPTDF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while PPTDF trades at $8.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PPTDF's P/E ratio is -45.86. In terms of profitability, FPHAF's ROE is +0.00%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, FPHAF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
FPHAF vs PHGUF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PHGUF has a market cap of 1.1B. Regarding current trading prices, FPHAF is priced at $3.30, while PHGUF trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PHGUF's P/E ratio is -151.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, FPHAF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check PHGUF's competition here
FPHAF vs NURPF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, FPHAF is priced at $3.30, while NURPF trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NURPF's P/E ratio is 51.38. In terms of profitability, FPHAF's ROE is +0.00%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, FPHAF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
FPHAF vs BTTAY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, FPHAF is priced at $3.30, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, FPHAF's ROE is +0.00%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, FPHAF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BTTAY's competition here
FPHAF vs TKBIF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, FPHAF is priced at $3.30, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, FPHAF's ROE is +0.00%, compared to TKBIF's ROE of N/A. Regarding short-term risk, FPHAF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
FPHAF vs BPMUF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BPMUF has a market cap of 871.4M. Regarding current trading prices, FPHAF is priced at $3.30, while BPMUF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BPMUF's P/E ratio is 9.97. In terms of profitability, FPHAF's ROE is +0.00%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, FPHAF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
FPHAF vs IVEVF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IVEVF has a market cap of 764.8M. Regarding current trading prices, FPHAF is priced at $3.30, while IVEVF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IVEVF's P/E ratio is -2.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to IVEVF's ROE of +6.13%. Regarding short-term risk, FPHAF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
FPHAF vs VBIZF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, VBIZF has a market cap of 724.5M. Regarding current trading prices, FPHAF is priced at $3.30, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, FPHAF's ROE is +0.00%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, FPHAF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
FPHAF vs CKDXF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, FPHAF is priced at $3.30, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, FPHAF's ROE is +0.00%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, FPHAF and CKDXF have similar daily volatility (0.00).Check CKDXF's competition here
FPHAF vs GNFTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNFTF has a market cap of 522.3M. Regarding current trading prices, FPHAF is priced at $3.30, while GNFTF trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNFTF's P/E ratio is -11.59. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, FPHAF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GNFTF's competition here
FPHAF vs INRLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, INRLF has a market cap of 499.1M. Regarding current trading prices, FPHAF is priced at $3.30, while INRLF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas INRLF's P/E ratio is -3.72. In terms of profitability, FPHAF's ROE is +0.00%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, FPHAF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check INRLF's competition here
FPHAF vs SOLTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SOLTF has a market cap of 477.8M. Regarding current trading prices, FPHAF is priced at $3.30, while SOLTF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SOLTF's P/E ratio is -6.07. In terms of profitability, FPHAF's ROE is +0.00%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, FPHAF and SOLTF have similar daily volatility (0.00).Check SOLTF's competition here
FPHAF vs RAONF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, FPHAF is priced at $3.30, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas RAONF's P/E ratio is -43.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, FPHAF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check RAONF's competition here
FPHAF vs GNFTY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, FPHAF is priced at $3.30, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, FPHAF's ROE is +0.00%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, FPHAF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check GNFTY's competition here
FPHAF vs TBGNF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, FPHAF is priced at $3.30, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, FPHAF's ROE is +0.00%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, FPHAF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
FPHAF vs CLVLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLF has a market cap of 424.1M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLF's P/E ratio is 16.90. In terms of profitability, FPHAF's ROE is +0.00%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, FPHAF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
FPHAF vs NWPHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, FPHAF is priced at $3.30, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWPHF's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, FPHAF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NWPHF's competition here
FPHAF vs AVCTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AVCTF has a market cap of 390.7M. Regarding current trading prices, FPHAF is priced at $3.30, while AVCTF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AVCTF's P/E ratio is -5.95. In terms of profitability, FPHAF's ROE is +0.00%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, FPHAF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
FPHAF vs PTCHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PTCHF has a market cap of 379.7M. Regarding current trading prices, FPHAF is priced at $3.30, while PTCHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PTCHF's P/E ratio is 9.18. In terms of profitability, FPHAF's ROE is +0.00%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, FPHAF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
FPHAF vs CYDY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CYDY has a market cap of 368.4M. Regarding current trading prices, FPHAF is priced at $3.30, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CYDY's P/E ratio is -9.67. In terms of profitability, FPHAF's ROE is +0.00%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, FPHAF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check CYDY's competition here
FPHAF vs CLVLY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CLVLY has a market cap of 338.5M. Regarding current trading prices, FPHAF is priced at $3.30, while CLVLY trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CLVLY's P/E ratio is 14.98. In terms of profitability, FPHAF's ROE is +0.00%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, FPHAF and CLVLY have similar daily volatility (0.00).Check CLVLY's competition here
FPHAF vs NGENF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, FPHAF is priced at $3.30, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NGENF's P/E ratio is -15.19. In terms of profitability, FPHAF's ROE is +0.00%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, FPHAF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NGENF's competition here
FPHAF vs NWBO Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NWBO has a market cap of 308.1M. Regarding current trading prices, FPHAF is priced at $3.30, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NWBO's P/E ratio is -3.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to NWBO's ROE of +0.92%. Regarding short-term risk, FPHAF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check NWBO's competition here
FPHAF vs FGHQF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, FPHAF is priced at $3.30, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, FPHAF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
FPHAF vs PBBIF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, FPHAF is priced at $3.30, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, FPHAF's ROE is +0.00%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, FPHAF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
FPHAF vs SLNCF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SLNCF has a market cap of 283.4M. Regarding current trading prices, FPHAF is priced at $3.30, while SLNCF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SLNCF's P/E ratio is -3.17. In terms of profitability, FPHAF's ROE is +0.00%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, FPHAF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
FPHAF vs SPHDF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHDF has a market cap of 275.5M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHDF trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHDF's P/E ratio is -2.91. In terms of profitability, FPHAF's ROE is +0.00%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, FPHAF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
FPHAF vs ORPOF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, FPHAF is priced at $3.30, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, FPHAF's ROE is +0.00%, compared to ORPOF's ROE of N/A. Regarding short-term risk, FPHAF and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
FPHAF vs ORYZF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, FPHAF is priced at $3.30, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, FPHAF's ROE is +0.00%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, FPHAF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
FPHAF vs HLOSF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, FPHAF is priced at $3.30, while HLOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, FPHAF's ROE is +0.00%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, FPHAF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
FPHAF vs HNSBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, FPHAF is priced at $3.30, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HNSBF's P/E ratio is -4.20. In terms of profitability, FPHAF's ROE is +0.00%, compared to HNSBF's ROE of +1.23%. Regarding short-term risk, FPHAF and HNSBF have similar daily volatility (0.00).Check HNSBF's competition here
FPHAF vs CMVLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, FPHAF is priced at $3.30, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CMVLF's P/E ratio is -9.33. In terms of profitability, FPHAF's ROE is +0.00%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, FPHAF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
FPHAF vs CAIHF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, FPHAF is priced at $3.30, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, FPHAF's ROE is +0.00%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, FPHAF and CAIHF have similar daily volatility (0.00).Check CAIHF's competition here
FPHAF vs BOVNF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, FPHAF is priced at $3.30, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, FPHAF and BOVNF have similar daily volatility (0.00).Check BOVNF's competition here
FPHAF vs ADOCY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, FPHAF is priced at $3.30, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, FPHAF's ROE is +0.00%, compared to ADOCY's ROE of +1.86%. Regarding short-term risk, FPHAF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
FPHAF vs SPHRY Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHRY has a market cap of 153.8M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHRY trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHRY's P/E ratio is -73.10. In terms of profitability, FPHAF's ROE is +0.00%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, FPHAF is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check SPHRY's competition here
FPHAF vs SCNLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SCNLF has a market cap of 151.1M. Regarding current trading prices, FPHAF is priced at $3.30, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SCNLF's P/E ratio is -14.56. In terms of profitability, FPHAF's ROE is +0.00%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, FPHAF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
FPHAF vs MLLCF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MLLCF has a market cap of 150.8M. Regarding current trading prices, FPHAF is priced at $3.30, while MLLCF trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MLLCF's P/E ratio is -1.09. In terms of profitability, FPHAF's ROE is +0.00%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, FPHAF and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
FPHAF vs SPHRF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, FPHAF is priced at $3.30, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, FPHAF and SPHRF have similar daily volatility (0.00).Check SPHRF's competition here
FPHAF vs TRGNF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, TRGNF has a market cap of 144.2M. Regarding current trading prices, FPHAF is priced at $3.30, while TRGNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas TRGNF's P/E ratio is -3.03. In terms of profitability, FPHAF's ROE is +0.00%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, FPHAF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check TRGNF's competition here
FPHAF vs AMGXF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, FPHAF is priced at $3.30, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, FPHAF's ROE is +0.00%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, FPHAF and AMGXF have similar daily volatility (0.00).Check AMGXF's competition here
FPHAF vs KNTPF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, KNTPF has a market cap of 140.7M. Regarding current trading prices, FPHAF is priced at $3.30, while KNTPF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas KNTPF's P/E ratio is -5.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, FPHAF and KNTPF have similar daily volatility (0.00).Check KNTPF's competition here
FPHAF vs BRIBF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, FPHAF is priced at $3.30, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, FPHAF's ROE is +0.00%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, FPHAF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
FPHAF vs HBPCF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, FPHAF is priced at $3.30, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, FPHAF's ROE is +0.00%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, FPHAF and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
FPHAF vs IPHYF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, IPHYF has a market cap of 128.7M. Regarding current trading prices, FPHAF is priced at $3.30, while IPHYF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas IPHYF's P/E ratio is -2.18. In terms of profitability, FPHAF's ROE is +0.00%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, FPHAF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
FPHAF vs JWCTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, JWCTF has a market cap of 127.8M. Regarding current trading prices, FPHAF is priced at $3.30, while JWCTF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas JWCTF's P/E ratio is -1.62. In terms of profitability, FPHAF's ROE is +0.00%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, FPHAF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
FPHAF vs AAPGV Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, FPHAF is priced at $3.30, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas AAPGV's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, FPHAF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check AAPGV's competition here
FPHAF vs PSTTF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, FPHAF is priced at $3.30, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, FPHAF's ROE is +0.00%, compared to PSTTF's ROE of N/A. Regarding short-term risk, FPHAF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
FPHAF vs NDTP Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, NDTP has a market cap of 116.6M. Regarding current trading prices, FPHAF is priced at $3.30, while NDTP trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas NDTP's P/E ratio is -2.43. In terms of profitability, FPHAF's ROE is +0.00%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, FPHAF and NDTP have similar daily volatility (0.00).Check NDTP's competition here
FPHAF vs ATGGF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ATGGF has a market cap of 113.5M. Regarding current trading prices, FPHAF is priced at $3.30, while ATGGF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ATGGF's P/E ratio is N/A. In terms of profitability, FPHAF's ROE is +0.00%, compared to ATGGF's ROE of -1.34%. Regarding short-term risk, FPHAF and ATGGF have similar daily volatility (0.00).Check ATGGF's competition here
FPHAF vs EPRXF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, FPHAF is priced at $3.30, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, FPHAF's ROE is +0.00%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, FPHAF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check EPRXF's competition here
FPHAF vs ADOIF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, FPHAF is priced at $3.30, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, FPHAF's ROE is +0.00%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, FPHAF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
FPHAF vs MSCLF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, FPHAF is priced at $3.30, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, FPHAF's ROE is +0.00%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, FPHAF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MSCLF's competition here
FPHAF vs BSEM Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, BSEM has a market cap of 87.5M. Regarding current trading prices, FPHAF is priced at $3.30, while BSEM trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas BSEM's P/E ratio is 5.91. In terms of profitability, FPHAF's ROE is +0.00%, compared to BSEM's ROE of -0.14%. Regarding short-term risk, FPHAF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check BSEM's competition here
FPHAF vs MCURF Comparison April 2026
FPHAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FPHAF stands at 209.5M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, FPHAF is priced at $3.30, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FPHAF currently has a P/E ratio of -7.50, whereas MCURF's P/E ratio is -16.90. In terms of profitability, FPHAF's ROE is +0.00%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, FPHAF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for FPHAF.Check MCURF's competition here